-
1
-
-
84893549987
-
-
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, 2014; 311:507-520.
-
(2014)
Dennison-Himmelfarb C
, vol.311
, pp. 507-520
-
-
James, P.A.1
Oparil, S.2
Carter, B.L.3
Cushman, W.C.4
-
3
-
-
84880015206
-
The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension
-
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31:1281-1357
-
(2013)
J Hypertens
, vol.31
, pp. 1281-1357
-
-
Mancia, G.1
Fagard, R.2
Narkiewicz, K.3
Redon, J.4
Zanchetti, A.5
Böhm, M.6
-
4
-
-
84880930315
-
-
Eur Heart J 2013; 34:2159-2219.
-
(2013)
Eur Heart J
, vol.34
, pp. 2159-2219
-
-
-
5
-
-
70449851433
-
Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document
-
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
-
(2009)
J Hypertens
, vol.27
, pp. 2121-2158
-
-
Mancia, G.1
Laurent, S.2
Agabiti-Rosei, E.3
Ambrosioni, E.4
Burnier, M.5
Caulfield, M.J.6
-
6
-
-
67649651744
-
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal
-
Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009; 27:923-934.
-
(2009)
J Hypertens
, vol.27
, pp. 923-934
-
-
Zanchetti, A.1
Grassi, G.2
Mancia, G.3
-
7
-
-
0022469583
-
Randomised trial of treatment of hypertension in elderly patients in primary care
-
Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986; 293:1145-1151. (Pubitemid 16008923)
-
(1986)
British Medical Journal
, vol.293
, Issue.6555
, pp. 1145-1151
-
-
Coope, J.1
Warrender, T.S.2
-
8
-
-
0021864792
-
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial
-
Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1:1349-1354. (Pubitemid 15060905)
-
(1985)
Lancet
, vol.1
, Issue.8442
, pp. 1349-1354
-
-
Amery, A.1
Brixko, P.2
Clement, D.3
-
9
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
-
SHEP Collaborative Research Group
-
SHEP Collaborative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
10
-
-
0343487983
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
-
DOI 10.1016/S0140-6736(97)05381-6
-
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350:757-764. (Pubitemid 27387202)
-
(1997)
Lancet
, vol.350
, Issue.9080
, pp. 757-764
-
-
Staessen, J.A.1
Fagard, R.2
Thijs, L.3
Celis, H.4
Arabidze, G.G.5
Birkenhager, W.H.6
Bulpitt, C.J.7
De Leeuw, P.W.8
Dollery, C.T.9
Fletcher, A.E.10
Forette, F.11
Leonetti, G.12
Nachev, C.13
O'Brien, E.T.14
Rosenfeld, J.15
Rodicio, J.L.16
Tuomilehto, J.17
Zanchetti, A.18
-
11
-
-
0031769003
-
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
-
DOI 10.1097/00004872-199816120-00016
-
Liu L, Wang JL, Gong L, Liu G, Staessen JA, for the Syst-China Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16:1823-1829. (Pubitemid 28548522)
-
(1998)
Journal of Hypertension
, vol.16
, Issue.12
, pp. 1823-1829
-
-
Liu, L.1
Wang, J.G.2
Gong, L.3
Liu, G.4
Staessen, J.A.5
-
12
-
-
0026512315
-
Principal results
-
MRC Working Party Medical Research Council trial of treatment of hypertension in older adults
-
MRC Working Party Medical Research Council trial of treatment of hypertension in older adults. Principal results. BMJ 1992; 304:405-412.
-
(1992)
BMJ
, vol.304
, pp. 405-412
-
-
-
13
-
-
0025942936
-
Morbidity and mortality in the Swedish Trial in OLd Patients with Hypertension (STOP-Hypertension)
-
Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in OLd Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338:1281-1285.
-
(1991)
Lancet
, vol.338
, pp. 1281-1285
-
-
Dahlöf, B.1
Lindholm, L.H.2
Hansson, L.3
Schersten, B.4
Ekbom, T.5
Wester, P.O.6
-
14
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
DOI 10.1016/S0140-6736(98)04311-6
-
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351:1755-1762. (Pubitemid 28269185)
-
(1998)
Lancet
, vol.351
, Issue.9118
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
15
-
-
0027314170
-
The Hypertension Optimal Treatment Study (The HOT Study)
-
The HOT Study Group. The Hypertension Optimal Treatment Study (The HOT Study). Blood Pressure 1993; 2:62-68.
-
(1993)
Blood Pressure
, vol.2
, pp. 62-68
-
-
Hot Study Group, T.1
-
16
-
-
10544229794
-
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
-
DOI 10.1001/jama.276.23.1886
-
Curb JD, Pressels SL, Cutler JA, Savage PJ, Appelgate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276:1886-1892. (Pubitemid 26419185)
-
(1996)
Journal of the American Medical Association
, vol.276
, Issue.23
, pp. 1886-1892
-
-
Curb, J.D.1
Pressel, S.L.2
Cutler, J.A.3
Savage, P.J.4
Applegate, W.B.5
Black, H.6
Camel, G.7
Davis, B.R.8
Frost, P.H.9
Gonzalez, N.10
Guthrie, G.11
Oberman, A.12
Rutan, G.H.13
Stamler, J.14
-
17
-
-
0033522149
-
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
-
DOI 10.1056/NEJM199903043400902
-
Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, Bulpitt CJ, et al. Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trials Investigators. N Engl J Med 1999; 340:677-684. (Pubitemid 29110751)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.9
, pp. 677-684
-
-
Tuomilehto, J.1
Rastenyte, D.2
Birkenhager, W.H.3
Thijs, L.4
Antikainen, R.5
Bulpitt, C.J.6
Fletcher, A.E.7
Forette, F.8
Goldhaber, A.9
Palatini, P.10
Sarti, C.11
Fagard, R.12
Staessen, J.A.13
-
18
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPPDS 38
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPPDS 38. BMJ 1998; 317:703-713.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
|